Ratings by Wells Fargo (Ben Burnett)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/3/2026 | Ultragenyx Pharma | RARE | Downgrade | Equal Weight (Overweight) |
26.53 (14.65) |
-44.78% | Details | |
| 8/28/2026 | Ultragenyx Pharma | RARE | Maintain | Overweight (N/A) |
|
Details | ||
| 8/20/2026 | Ultragenyx Pharma | RARE | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/7/2026 | Tectonic Therapeutics Inc. | TECX | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/7/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 8/7/2026 | Insmed | INSM | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/6/2026 | United Therapeutics Corp. | UTHR | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2026 | MannKind | MNKD | Maintain | Overweight (N/A) |
|
Details | ||
| 8/5/2026 | Ultragenyx Pharma | RARE | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/4/2026 | Keros Therapeutics | KROS | Maintain | Overweight (Overweight) |
|
Details | ||
| 7/31/2026 | PTC Therapeutics | PTCT | Maintain | Overweight (Overweight) |
|
Details | ||
| 7/30/2026 | MannKind | MNKD | Maintain | Overweight (Overweight) |
|
Details | ||
| 7/20/2026 | PTC Therapeutics | PTCT | Maintain | Overweight (Overweight) |
|
Details | ||
| 7/15/2026 | Insmed | INSM | Maintain | Overweight (Overweight) |
|
Details | ||
| 6/29/2026 | Alkermes | ALKS | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/20/2026 | WAVE Life Sciences | WVE | Maintain | Overweight (N/A) |
|
Details | ||
| 5/12/2026 | Liquidia Technologies | LQDA | Maintain | Overweight (N/A) |
|
Details | ||
| 5/8/2026 | Insmed | INSM | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/8/2026 | PTC Therapeutics | PTCT | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/7/2026 | MannKind | MNKD | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/7/2026 | United Therapeutics Corp. | UTHR | Upgrade | Overweight (Equal Weight) |
596.76 (493.10) |
-17.37% | Details | |
| 5/6/2026 | Ultragenyx Pharma | RARE | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/6/2026 | Alkermes | ALKS | Maintain | Overweight (Overweight) |
|
Details | ||
| 4/28/2026 | MannKind | MNKD | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/31/2026 | United Therapeutics Corp. | UTHR | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 3/27/2026 | WAVE Life Sciences | WVE | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/23/2026 | United Therapeutics Corp. | UTHR | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 3/23/2026 | Liquidia Technologies | LQDA | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/23/2026 | Insmed | INSM | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/11/2026 | Rapport Therapeutics | RAPP | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/6/2026 | Liquidia Technologies | LQDA | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/5/2026 | Keros Therapeutics | KROS | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/27/2026 | MannKind | MNKD | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/26/2026 | United Therapeutics Corp. | UTHR | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 2/26/2026 | Alkermes | ALKS | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/20/2026 | PTC Therapeutics | PTCT | Maintain | Overweight (N/A) |
|
Details | ||
| 2/20/2026 | Insmed | INSM | Maintain | Overweight (N/A) |
|
Details | ||
| 2/12/2026 | WAVE Life Sciences | WVE | Maintain | Overweight (Overweight) |
|
Details | ||
| 12/30/2025 | Ultragenyx Pharma | RARE | Maintain | Overweight (N/A) |
|
Details | ||
| 12/18/2025 | Savara | SVRA | Maintain | Overweight (Overweight) |
|
Details | ||
| 12/16/2025 | Insmed | INSM | Maintain | Overweight (Overweight) |
|
Details | ||
| 12/9/2025 | WAVE Life Sciences | WVE | Maintain | Overweight (Overweight) |
|
Details | ||
| 11/11/2025 | WAVE Life Sciences | WVE | Maintain | Overweight (Overweight) |
|
Details | ||
| 11/11/2025 | MannKind | MNKD | Maintain | Overweight (Overweight) |
|
Details | ||
| 11/11/2025 | Keros Therapeutics | KROS | Maintain | Overweight (Overweight) |
|
Details | ||
| 11/5/2025 | PTC Therapeutics | PTCT | Maintain | Overweight (N/A) |
|
Details | ||
| 10/31/2025 | Insmed | INSM | Maintain | Overweight (Overweight) |
|
Details | ||
| 10/30/2025 | United Therapeutics Corp. | UTHR | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 10/20/2025 | WAVE Life Sciences | WVE | New Coverage | Overweight (N/A) |
7.81 (4.26) |
-45.45% | Details | |
| 10/20/2025 | United Therapeutics Corp. | UTHR | New Coverage | Underweight (N/A) |
433.34 (596.76) |
37.71% | Details | |
| 10/20/2025 | Tectonic Therapeutics Inc. | TECX | New Coverage | Overweight (N/A) |
17.26 (26.63) |
54.29% | Details | |
| 10/20/2025 | Savara | SVRA | New Coverage | Overweight (N/A) |
3.61 (5.45) |
50.97% | Details | |
| 10/20/2025 | Ultragenyx Pharma | RARE | New Coverage | Overweight (N/A) |
32.63 (14.65) |
-55.1% | Details | |
| 10/20/2025 | PTC Therapeutics | PTCT | New Coverage | Overweight (N/A) |
65.95 (65.26) |
-1.05% | Details | |
| 10/20/2025 | MannKind | MNKD | New Coverage | Overweight (N/A) |
5.47 (3.50) |
-36.01% | Details | |
| 10/20/2025 | Liquidia Technologies | LQDA | New Coverage | Overweight (N/A) |
22.48 (66.43) |
195.51% | Details | |
| 10/20/2025 | Keros Therapeutics | KROS | New Coverage | Overweight (N/A) |
13.83 (11.48) |
-16.99% | Details | |
| 10/20/2025 | Insmed | INSM | New Coverage | Overweight (N/A) |
165.76 (121.00) |
-27% | Details |
